Augmedix (AUGX)
(Delayed Data from NSDQ)
$2.27 USD
+0.01 (0.44%)
Updated Aug 9, 2024 03:59 PM ET
After-Market: $2.27 0.00 (0.00%) 7:58 PM ET
3-Hold of 5 3
D Value D Growth C Momentum D VGM
Fundamental Charts
About PEG Ratio (TTM)
The company's trailing twelve month (TTM) PEG ratio is the P/E ratio divided by its long-term growth rate consensus. This ratio essentially compares the P/E to its growth rate, thus, for many, telling a more complete story than just the P/E ratio alone. Conventional wisdom says that a PEG ratio of 1 or less is considered good (at par or undervalued to its growth rate). A value greater than 1, in general, is not as good (overvalued to its growth rate). For example, a company with a P/E ratio of 25 and a growth rate of 20% would have a PEG ratio of 1.25 (25 / 20 = 1.25). A company with a P/E ratio of 40 and a growth rate of 50% would have a PEG ratio of 0.80 (40 / 50 = 0.80). Traditionally, investors would look at the stock with the lower P/E and deem it a bargain. But when compared to its growth rate, it doesn't have the earnings growth to justify its P/E. In this example, the one with the P/E of 40 is the better bargain because it is selling at a discount to its growth rate. So the PEG ratio tells you what you're paying for each unit of earnings growth.
AUGX 2.27 +0.01(0.44%)
Will AUGX be a Portfolio Killer in August?
Zacks Investment Research is releasing its prediction for AUGX based on the 1-3 month trading system that more than doubles the S&P 500.
Zacks News for AUGX
Aveanna Healthcare (AVAH) Beats Q2 Earnings and Revenue Estimates
Health Catalyst (HCAT) Q1 Earnings Beat Estimates
AUGX: What are Zacks experts saying now?
Zacks Private Portfolio Services
How Much Upside is Left in Augmedix, Inc. (AUGX)? Wall Street Analysts Think 36.67%
Augmedix, Inc. (AUGX) is on the Move, Here's Why the Trend Could be Sustainable
Privia Health (PRVA) Q3 Earnings Miss Estimates
Other News for AUGX
Augmedix to Announce Second Quarter 2024 Financial Results on August 12, 2024
The 3 Stocks Every Investor Should Be Selling in July
Maintaining Hold Rating for Augmedix Amidst Acquisition and Challenging Financial Outlook
Augmedix just downgraded at Lake Street, here's why
Why Selective Insurance Group Shares Are Trading Lower By Around 15%? Here Are Other Stocks Moving In Friday's Mid-Day Session